Allurion Technologies, Inc. (NYSE: ALUR)
$3.4000
+0.2600 ( +8.63% ) 70.0K
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Market Data
Open
$3.4000
Previous close
$3.1400
Volume
70.0K
Market cap
$8.54M
Day range
$3.0650 - $3.4800
52 week range
$2.7200 - $98.7500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Nov 08, 2024 |
def | Proxies and info statements | 5 | Nov 08, 2024 |
8-k | 8K-related | 12 | Nov 04, 2024 |
8-k | 8K-related | 11 | Oct 28, 2024 |
pre | Proxies and info statements | 5 | Oct 28, 2024 |
3 | Insider transactions | 2 | Sep 12, 2024 |
8-k | 8K-related | 12 | Sep 05, 2024 |
8-k | 8K-related | 13 | Sep 04, 2024 |
8-k | 8K-related | 12 | Aug 15, 2024 |
10-q | Quarterly Reports | 102 | Aug 14, 2024 |